Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AITECS is a medical technology brand specializing in the development and manufacturing of high-precision infusion therapy systems. Originally founded as Viltechmeda in Lithuania, the company is best known for its AITECS series of syringe and volumetric pumps designed for critical care environments. These devices are widely utilized in anesthesia, neonatology, and oncology to ensure accurate delivery of potent medications. Over the years, the company has undergone several ownership changes, being acquired by Moog Inc. in 2009, then sold to Smiths Medical in 2017, and finally becoming part of ICU Medical in 2022. Today, AITECS products remain a core component of ICU Medical's global infusion systems portfolio, serving healthcare providers with reliable medication delivery solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AITECS Medical.